RF26 | PMON332 Safety and Efficacy of Treatment with Lonapegsomatropin in Children with Growth Hormone Deficiency at Week 130 in the enliGHten Trial

por Saenger, Paul, Nadgir, Ulhas, Hofman, Paul, Thornton, Paul, Chertok, Elena D, Aghajanova, Elena M, Korpal-Szczyrska, Maria, Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Chaychenko, Tetyana, Cappa, Marco, Song, Wenjie, Mao, Meng, Chessler, Steven D, Komirenko, Allison S, Beckert, Michael, Shu, Aimee D, Maniatis, Aristides K
Publicado 2022

Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results

por Maniatis, Aristides K, Casella, Samuel J, Nadgir, Ulhas M, Hofman, Paul L, Saenger, Paul, Chertock, Elena D, Aghajanova, Elena M, Korpal-Szczyrska, Maria, Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Chaychenko, Tetyana, Cappa, Marco, Song, Wenjie, Mao, Meng, Mygind, Per Holse, Smith, Alden R, Chessler, Steven D, Komirenko, Allison S, Beckert, Michael, Shu, Aimee D, Thornton, Paul S
Publicado 2022